Product Information
NEBIVOLOL 5 MG TABLET is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $0.1134 per EA under NDC 72205015130. Its NADAC has been published 69 times since Jun 11, 2025.
FDA first approved this application on Oct 1, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205015130
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NEBIVOLOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA217397FDA Approved
10/1/2024
TE Code
AB
On Market Since
10/1/2024
Pharmacological Classes
Price Statistics
The NADAC for NEBIVOLOL 5 MG TABLET has been published 69 times since Jun 11, 2025, and over the history we have for it it has declined 3.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1134 per EA |
|---|---|
| All-time high | $0.1179 (Jun 11, 2025) |
| All-time low | $0.0974 (Mar 18, 2026) |
| 52-week high | $0.1134 |
| 52-week low | $0.0974 |
| Median price | $0.1094 |
| Average price | $0.1082 |
| Largest weekly change | -9.0% (Feb 18, 2026) |
| Weeks tracked | 69 |
| Tracking since | Jun 11, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Novadoz Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
NEBIVOLOL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NEBIVOLOL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NEBIVOLOL 5 MG TABLET, manufactured by Novadoz Pharmaceuticals LLC, is $0.1134 per EA (NDC 72205015130), effective Sep 30, 2026.
How has the price of NEBIVOLOL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for NEBIVOLOL 5 MG TABLET has declined 3.8%. It has been tracked across 69 weekly CMS publications since Jun 11, 2025.
What are the highest and lowest recorded NADAC prices for NEBIVOLOL 5 MG TABLET?
Since Jun 11, 2025, the NADAC for NEBIVOLOL 5 MG TABLET has ranged from a low of $0.0974 (Mar 18, 2026) to a high of $0.1179 (Jun 11, 2025), with a median of $0.1094 per EA.
Are there cheaper alternatives to NEBIVOLOL 5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NEBIVOLOL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures NEBIVOLOL 5 MG TABLET?
NEBIVOLOL 5 MG TABLET (NDC 72205015130) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.